These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

344 related items for PubMed ID: 12497672

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Individualization of low-dose oral contraceptives. Pharmacological principles and practical indications for oral contraceptives].
    Cianci A, De Leo V.
    Minerva Ginecol; 2007 Aug; 59(4):415-25. PubMed ID: 17923832
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Efficacy and safety of a low-dose 24-day combined oral contraceptive containing 20 micrograms ethinylestradiol and 3 mg drospirenone.
    Bachmann G, Sulak PJ, Sampson-Landers C, Benda N, Marr J.
    Contraception; 2004 Sep; 70(3):191-8. PubMed ID: 15325887
    [Abstract] [Full Text] [Related]

  • 7. Effect of a combination of ethinylestradiol 30 microg and drospirenone 3 mg on tolerance, cycle control, general well-being and fluid-related symptoms in women with premenstrual disorders requesting contraception.
    Borges LE, Andrade RP, Aldrighi JM, Guazelli C, Yazlle ME, Isaia CF, Petracco A, Peixoto FC, Camargos AF.
    Contraception; 2006 Dec; 74(6):446-50. PubMed ID: 17157100
    [Abstract] [Full Text] [Related]

  • 8. A prospective randomized trial comparing low-dose ethinyl estradiol and drospirenone 24/4 combined oral contraceptive vs. ethinyl estradiol and drospirenone 21/7 combined oral contraceptive in the treatment of hirsutism.
    Oner G, Muderris II.
    Contraception; 2011 Nov; 84(5):508-11. PubMed ID: 22018126
    [Abstract] [Full Text] [Related]

  • 9. Treatment of acne using a 3-milligram drospirenone/20-microgram ethinyl estradiol oral contraceptive administered in a 24/4 regimen: a randomized controlled trial.
    Maloney JM, Dietze P, Watson D, Niknian M, Lee-Rugh S, Sampson-Landers C, Korner P.
    Obstet Gynecol; 2008 Oct; 112(4):773-81. PubMed ID: 18827119
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Use of an oral contraceptive containing drospirenone in an extended regimen.
    Sillem M, Schneidereit R, Heithecker R, Mueck AO.
    Eur J Contracept Reprod Health Care; 2003 Sep; 8(3):162-9. PubMed ID: 14667328
    [Abstract] [Full Text] [Related]

  • 12. Yasmin: the reason why.
    Thorneycroft IH.
    Eur J Contracept Reprod Health Care; 2002 Dec; 7 Suppl 3():13-8; discussion 42-3. PubMed ID: 12659402
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Drospirenone: a novel progestin.
    Rapkin AJ, Winer SA.
    Expert Opin Pharmacother; 2007 May; 8(7):989-99. PubMed ID: 17472544
    [Abstract] [Full Text] [Related]

  • 15. Serum potassium monitoring for users of ethinyl estradiol/drospirenone taking medications predisposing to hyperkalemia: physician compliance and survey of knowledge and attitudes.
    Mona Eng P, Seeger JD, Loughlin J, Oh K, Walker AM.
    Contraception; 2007 Feb; 75(2):101-7. PubMed ID: 17241838
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Risk of venous thromboembolism with drospirenone in combined oral contraceptive products.
    Sehovic N, Smith KP.
    Ann Pharmacother; 2010 May; 44(5):898-903. PubMed ID: 20371756
    [Abstract] [Full Text] [Related]

  • 18. [Efficacy and safety of drospirenone-ethinylestradiol on contraception in healthy Chinese women: a multicenter randomized controlled trial].
    Fan GS, Bian ML, Cheng LN, Cao XM, Huang ZR, Han ZY, Jing XP, Li J, Wu SY, Xiong CL, Xiong ZA, Yue TF.
    Zhonghua Fu Chan Ke Za Zhi; 2009 Jan; 44(1):38-44. PubMed ID: 19563061
    [Abstract] [Full Text] [Related]

  • 19. Nomegestrol acetate/estradiol: in oral contraception.
    Yang LP, Plosker GL.
    Drugs; 2012 Oct 01; 72(14):1917-28. PubMed ID: 22950535
    [Abstract] [Full Text] [Related]

  • 20. A new monophasic oral contraceptive containing drospirenone. Effect on premenstrual symptoms.
    Brown C, Ling F, Wan J.
    J Reprod Med; 2002 Jan 01; 47(1):14-22. PubMed ID: 11838304
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.